New Member Joins CQDM’s Board of Directors: A Strategic Health Innovation Expert CQDM is proud to welcome Stephanie Michaud to its Board of Directors.A close partner of the organization since its early days, she brings in-depth knowledge of our mission, activities, and evolution. A recognized expert in health innovation and innovation policy, Stéphanie is a…
We’ve officially launched the first-ever Canadian cohort of the Merck Digital Sciences Studio (MDSS), right here in Québec — with the presence of Mr. Christopher Skeete, Minister for the Economy at Québec’s Ministry of Economy, Innovation and Energy. His participation highlights the province’s commitment to digital health innovation. This global program is locally powered by…
Announcement Montreal, June 19, 2025 – CQDM and the Stem Cell Network (SCN) join forces to fund a cutting-edge collaborative research project. It aims to evaluate the potential of an encapsulated liver tissue, developed by Morphocell Technologies, to treat urea cycle disorders in children. This research and development project, worth a total of $727,507, is…
CQDM is proud to highlight a major recognition awarded to its outgoing President and CEO, Diane Gosselin, who received the Community Leadership Award – Research & Innovation as part of BIOTECanada’s Gold Leaf Awards 2025. The award was presented in Boston, during the BIO 2025 International Convention—one of the world’s largest gatherings in the biopharmaceutical…
Seize the opportunities offered by RNA therapies and propel your business forward by investing in cutting-edge technologies. As part of AReNA – Québec’s RNA Hub, we are pleased to support the launch of a call for projects aimed at fostering the development of innovative technologies serving the RNA therapy sector.This program, funded by the Ministry…
Announcement BOSTON, June 16, 2025 – CQDM is proud to announce the funding of two collaborative research projects focused on the development of RNA-based therapies. Unveiled during the BIO International Convention in Boston, in the presence of Mr. Christopher Skeete, Minister for the Economy, Minister Responsible for the Fight Against Racism and Minister Responsible for…
Announcement BOSTON, June 17, 2025 – CQDM is proud to announce the addition of three leading Japanese pharmaceutical companies—Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., and McQuade Center for Strategic Research and Development (MSRD), an indirect subsidiary of Otsuka Pharmaceutical Co., Ltd.—to its growing biopharmaceutical consortium. This strategic expansion strengthens CQDM’s industry reach and reinforces…
A New Chapter Begins at CQDM Montreal, June 11, 2025 — Last night, CQDM paid a heartfelt and grateful tribute to its outgoing President and CEO, Diane Gosselin, co-founder of the organization, as she prepares to retire. Held in the presence of our committee members and many key players from the life sciences ecosystem, the…
CQDM and the Centre for Probe Development and Commercialization (CPDC) are pleased to announce a strategic initiative to support the development of next-generation radiopharmaceuticals in Canada. This collaboration represents a unique opportunity to align Canada’s strengths and global expertise in this expanding field. Together we are initiating a collective effort that will foster innovation and…
Announcement Montreal, May 14, 2025 – CQDM is proud to announce the funding of an innovative artificial intelligence (AI) project aimed at developing targeted therapies for various forms of cancer, alongside companion diagnostic tests designed to enhance patient selection in clinical settings. Valued at nearly $1.8 million, the initiative is led by two fast-growing Quebec…